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Abstract
OBJECTIVES: Current guidelines recommend prophylactic replacement of the ascending aorta at an aneurysmal diameter of >55 mm to
prevent acute Type A aortic dissection (TAAD) in non-Marfan patients. Several publications have challenged this threshold, suggesting that
surgery should be performed in smaller aneurysms to prevent this devastating disease. We reviewed our experience with measuring aortic
size at the time of TAAD to validate the existing recommendation for prophylactic ascending aorta replacement.
METHODS: All patients who had been admitted for TAAD to our emergency department from 2014 to 2019 and underwent ascending
aorta replacement were included. Marfan patients were excluded. The maximum diameter of the dissected aorta was measured
preoperatively using CT scan. We estimated the aortic diameter at the time of dissection to be 7 mm smaller than the measured maximum
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RESULTS: Overall, 102 patients were included. Of these, 67 were male (65.6%) and 35 were female (34.4%), and the cohort’s mean age was
65 ± 12.1 years. In addition, 66% were treated for arterial hypertension. The mean maximum modelled pre-dissection diameter was
39.6 ± 4.8 mm: 39.1 ± 5.1 mm in men and 40.7 ± 2.8 mm in women (P = 0.1). The cumulative 30-day mortality rate was 19.6% (20/102).
CONCLUSIONS: TAAD occurred at a modelled aortic diameter below 45 mm in 87.7% of our patients. Therefore, the current aortic diam-
eter threshold of 55 mm excludes 99% of patients with TAAD from prophylactic replacement of the ascending aorta. The maximum
diameter of the ascending aorta warrants reappraisal and this parameter should be a distinct part of a personalized decision-making pro-
cess that also takes into account age, gender and body surface area to establish the surgical indication for preventive aorta replacement
aimed to improve the survival benefit of this procedure.
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ABBREVIATIONS
BSA Body surface area
TAAD Type A aortic dissection
INTRODUCTION
Acute aortic dissection of the ascending aorta (Stanford classifica-
tion Type A) is a devastating disease that has an annual incidence
of 2.9/100 000 [1]. Mortality rates of medically managed Type A
acute aortic dissection (TAAD) are 20% at 24h after presentation,
30% at 48h, 40% at a week and 50% at a month after presenta-
tion [2, 3]. Therefore, surgical treatment is indicated immediately
upon TAAD diagnosis. Despite major improvements in surgical
techniques, cerebral perfusion protection strategies, and
perioperative care, surgical mortality remains high, even in high-
volume centres with the 30-day mortality of 7.6% and the opera-
tive mortality of 9.5% [2]. These rates have not significantly
changed over time for patients receiving immediate and ad-
equate surgical treatment.
Hospital-based databases only include patients who reach re-
ferral centres alive, and they exclude some 50% of TAAD
patients who die at home or prior to hospital admission. This
therefore leads to underestimating overall disease incidence
and mortality [3].
Current guidelines recommend prophylactic ascending
aorta replacement at an aneurysm diameter of >55 mm in an
effort to prevent acute TAAD (class I, level C), in the absence
of connective-tissue disorders [4]. These guidelines are
essentially based on expert consensus and retrospective obser-
vational studies. The milestone paper, which was published in
1997, is a single-centre study of a heterogeneous 76-patient co-
hort [5].
In recent years, several publications have challenged the >55-
mm threshold. Every single study that has looked at pre-
dissection diameters has found that only a small percentage of
TAAD patients actually had an aortic aneurysm above 55 mm.
This comprises all major international registries, such as the
International Registry for Aortic Dissections and German Registry
for Acute Aortic Dissection type A [6, 7]. Based on a cohort of
343 patients, Rylski et al. modelled the pre-dissection aortic
diameter from the dissected aorta by subtraction of the average
diameter increase rate of 30% (according to the results of a study
of human aortic geometry changes due to dissection). These
authors concluded that >90% failed to meet the guidelines for
elective ascending aorta replacement [8].
We have herein reviewed our experience of modelling pre-
dissection aortic size to possibly validate existing recommenda-
tions for prophylactic ascending aorta replacement.
METHODS
We retrospectively evaluated clinical data, including demograph-
ics and cardiovascular risk factors, of 117 patients who consecu-
tively underwent surgical treatment for TAAD in our institute and
received at least a graft on the ascending aorta from January
2014 to October 2019. Patients with a clinical diagnosis of
Marfan syndrome or connective-tissue disorders, iatrogenic or
traumatic dissection, or bicuspid aortic valve were excluded.
Within this cohort, we identified patients who had received ad-
equate computed tomography angiography upon emergency de-
partment admission and we retrieved their clinical data. The
following parameters were collected: date of birth, height,
weight, gender and diagnosis of arterial hypertension. We
defined the treatment of resistant systemic hypertension as
requiring at least 3 antihypertensive drugs, such as beta-blockers,
angiotensin-converting enzyme inhibitors, angiotensin II receptor
antagonists, vasodilators or calcium channel blockers.
Preoperative trans-oesophageal echocardiography was per-
formed to exclude the presence of a bicuspid aortic valve.
Amidst our cohort, the maximum diameter and length of the
dissected aorta were measured on pre-operatory contrast-me-
dium CT scan. Centre line reconstructions were generated using
the Carestream Health SA—Switzerland software package. Next,
the maximum aortic diameter including true and false lumens,
and outer to outer aortic wall diameter, was measured on axial
transverse images perpendicular to the central line on the
aortic segment between the sinotubular junction and origin of
the brachiocephalic trunk. Based on our assumption, this is the
most appropriate segment to study in patients without Marfan
syndrome or connective-tissue disorders and a tricuspid aortic
valve.
Finally, the aortic length was measured on centre line recon-
structions starting from the plane corresponding to the sinotubu-
lar junction to the plane immediately proximal to the origin of
the brachiocephalic artery (Figure 1). The manual identification
of the centre line was required in case of either no or low con-
trast enhancement of the false channel.
To model the pre-dissection aortic dimension, we considered
the 2 most recent publications on the effects of TAAD on aortic
geometry changes and increases in aortic diameter: namely, the
study by Rylski, in which the induced average increase in the
mid-ascending aortic diameter was 13 ± 7mm (+32%) [8], and
the study by Mansour, in which the pre-dissected aortic
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diameter was estimated to be 7 mm (-20%) smaller than the
measured dissected aorta [9]. We decided to arbitrarily apply
Mansour’s criteria to our cohort, so as to estimate pre-
dissection aortic dimensions and identified it as a modelled
pre-dissection diameter.
To compare our results with normal aortic size limits, the
modelled pre-dissection ascending aorta diameters were com-
pared between genders among 4 age categories (<45, 45–54, 55–
64 and >65) and referred to gender-specific, age-specific and
body surface area (BSA)-adjusted normal aortic diameters, as
reported in a study involving 2952 patients by Wolak et al. [10].
The statistics have been presented as frequencies and percen-
tages for categorical variables and as mean and standard devi-
ation for continuous variables. For comparison of the continuous
variables, the Mann–Whitney rank sum test was used. Categorical
variables were compared using the Chi-squared test. In the event
of small group sizes (n < 5), Fisher’s exact t-test was used.
The study protocol was reviewed and accepted by our local
ethics committee (authorization number 2020-01054), and we
received written informed consent from each patient.
RESULTS
In total, 117 patients underwent surgical replacement of the
ascending aorta, 28 (23.9%) of whom also received a prosthetic
aortic valve and 13 (11.1%) of whom underwent a Bentall pro-
cedure. Fifteen patients (12.8%) were excluded from the study: 8
were Marfan patients, whereas a preoperative CT scan could not
be found for the remaining 7. Of the 102 patients who were
included, there were 67 men (65.6%) and 35 women (34.4%), and
their mean age was 65 ± 12.1 years. Overall, 67 patients (66%)
were treated for arterial hypertension and 54% suffered
treatment-resistant hypertension. The cohort’s mean height was
173 ± 9 cm, and the mean weight was 80 ± 17.8 kg. The mean
maximum modelled pre-dissection diameter was 39.6 ± 4.8 mm,
which was 39.1 ± 5.1 mm in men and 40.7 ± 2.8 mm in women
(P = 0.1) (Figure 2). The mean length of the ascending aorta was
87 ± 22 mm (Figure 3). The mean intensive care unit stay was
8 ± 0 days (range: 1–48 days). The operative and 30-day cumula-
tive mortality rate was 19.6% (20/102). In total, 10 patients died
Figure 1: Centre line reconstructions of preoperative CT scan with contrast medium. (A) Patient 4: the maximum diameter of the dissected aorta was measured includ-
ing true and false lumens, outer to outer aortic wall diameter, on axial transverse images perpendicular to the central line. (B) Patient 37: measure of the length of the
ascending aorta. The ascending aorta begins at the plane corresponding to the sinotubular junction (white line 1) and extends to the plane immediately proximal to
the origin of the brachiocephalic artery (red line 2): 88.5 mm corresponds to the length of the dissected ascending aorta.
Figure 2: Distribution of pre-dissected maximum ascending aorta diameters,
according to size and gender. The pre-dissected (modelled) diameter was
obtained by measuring the maximum aortic diameter of the dissected ascend-
ing aorta of -7 mm, according to Mansour et al. results [9]. Grey columns cor-
respond to female gender. TAAD: Type A aortic dissection.
Figure 3: Scatter plot of dissected ascending aorta length. Aortic length was
measured on centre line reconstructions starting from the plane corresponding
to the sinotubular junction to the plane immediately proximal to the origin of
the brachiocephalic artery. One hundred twenty millimetres is the cut-off value
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due to neurological complications (10%), 9 died due to cardio-
vascular complications (haemorrhage, heart failure and intestinal
ischaemia) and the remaining 1 died from multiple organ failure.
None of the enrolled patients exhibited bicuspid aortic valves.
Pathological examination of the resected dissected aorta revealed
anomalies in all patients. Specifically, in 35 patients (34%) we
found cystic media necrosis characterized by the local disappear-
ance of elastic fibres in the arterial media, a reduction in smooth
muscle cells and an increase in proteoglycans; 67 patients (64%)
clearly presented only fragmentation of elastic fibres at the
Elastica van Gieson stain.
DISCUSSION
Prophylactic replacement of the ascending aorta is the only ef-
fective strategy for preventing TAAD. As with all preventive treat-
ments, a risk/benefit analysis appears crucial to determine the
appropriate timing for the surgical procedure. Unlike coronary
and cerebral vascular diseases, data on TAAD risk factors, inci-
dence, and outcome are limited and no prospective population-
based studies have been published as yet [3]. Several retrospect-
ive studies have highlighted the correlation between dissection
and arterial hypertension. Indeed, hypertension that is resistant
to medication has been shown to be the most significant modifi-
able risk factor for acute aortic dissection [3, 11]. The high rate of
treatment-resistant hypertension in TAAD patients is most prob-
ably due to decreased aortic compliance, which is associated
with fragility of the aortic wall. In our experience, 54% of patients
suffered from treatment-resistant hypertension, and all these sub-
group patients had an aortic diameter of smaller than 40 mm
upon dissection, without any significant difference in the inter-
gender variance of aortic diameters.
Although the exact sequence of events leading to TAAD
remains poorly understood, several studies have demonstrated
common pathways of medial degeneration. These comprise elas-
tic fibre fragmentation and smooth muscle cell necrosis, which
both lead to the progressive loss of aortic wall integrity and wall
delamination [12, 13]. None of our patients displayed a histologi-
cally normal aortic wall. Histological examination of the resected
dissected aorta demonstrated elastic fibre fragmentation in all
patients and cystic media necrosis in 34% of them. This supports
the hypothesis, which has been extensively described in the lit-
erature, that spontaneous aortic dissection does not occur in
normal aortic walls [12]. Information on pathological aortic wall
would play a key role in the decision-making process of prevent-
ive aortic replacement. Nevertheless, existing non-invasive inves-
tigational tools (ultrasounds, CT, and magnetic-resonance
imaging) are unable to characterize aortic wall histology.
The ascending aortic transverse diameter is the only accepted
morphological risk factor for TAAD and indication for preventive
surgery. However, this is a poor predictor of the timing and loca-
tion of dissection events. Historical studies using mathematical
models to simulate aortic dissection underline how a dilatation
phase of the ascending aorta (growing aorta) plays a key role in
producing an intimal tear, which is followed by the acute dissec-
tion process [14]. However, size alone only seems to be a good
predictor of ascending aortic dissection for diameters over
60 mm, which seems to be the hinge point for natural complica-
tions of aortic aneurysm [15, 16]. Approximately one-third of
patients with aortic dissection exhibit a normal-sized or
minimally enlarged aorta, and only 10% of patients display a true
ascending aortic aneurysm [15]. In our cohort, only 9 (8.8%)
patients had a pre-dissection aortic diameter larger than 55 mm.
An analysis of 3400 patients by the Yale Aortic Institute
Database, which contains data on patients who had, by chance,
an aortic CT scan just before aortic dissection, enabled Mansour
et al. [9] to claim that the pre-dissection ascending aortic size is
7.65 mm smaller, just before dissection occurred. This is because
rapid separation within the aortic media likely causes acute aortic
wall weakness, which should theoretically trigger an immediate
increase in aortic diameter. The reported threshold for the diam-
eter’s increase due to dissection has a 21% variation coefficient
upon measurements. This means that for a dissected aortic diam-
eter of 60 mm, for example the pre-dissection diameter was be-
tween 48 and 53 mm. Other authors have reported more
aggressive increases in aortic diameter due to acute dissection. In
an elegant study, Rylski et al. reported that the maximum diam-
eter of the ascending aorta increased by 12.8 mm (32%) from
40.1 mm (36.6 mm; 45.3 mm) to 52.9 mm (46.1 mm; 58.6 mm)
(+12.8 mm; +32%; P < 0.001). A similar but less pronounced in-
crease in dimensions was observed at the sinotubular junction
level (+6.9 mm; p < 0.001). In contrast, the sinus of Valsalva diam-
eter did not significantly increase [13].
If we apply the smallest correction of -7mm to our cohort, 51
(50%) TAAD patients probably displayed an aortic diameter that
was smaller than 40 mm, whereas 89 (87.7%) exhibited an aortic
diameter that was smaller than 45 mm at the time of dissection.
This suggests that the size criterion for resection of ascending
aorta aneurysm warrants reappraisal. In the personalized medi-
cine era, for small aneurysms, aortic size cannot remain the only
and absolute criterion for proposing the surgical replacement of
the ascending aorta. One possibility to improve the parameter’s
accuracy is to consider the aortic diameter with respect to age,
gender and BSA. In Table 1, we have stratified our cohort accord-
ing to gender, age and BSA at the time of dissection. We then
compared the modelled pre-dissection diameter to the ‘normal’
ascending aorta diameter for the same class of age, gender and
BSA, as reported by Wolak et al. [10]. Surprisingly, all patients
exhibited a modelled pre-dissection diameter between 10% and
34% larger than it was supposed to be, according to Wolak’s
data. This suggests that dissection occurs in dilated aorta with re-
spect to the standard diameter even when the absolute value is
below the accepted criteria for surgical resection. We have inte-
grated these findings into a personalized decision-making pro-
cess where an increase of at least 10% of patient aortic size with
respect to ‘normal’ size for same class of age, gender and BSA
represents an element in favour of early surgery. For example, in
a 70-year-old male with a BSA of 2.2 m2, an ascending aorta of
38 mm could be considered normal, whereas in a 45-year-old
woman with a BSA of 1.6 m2, this would signify an indication for
surgical replacement because the aorta is 30% larger than what is
considered as normal aortic diameter, this being 29.6 ± 2.8.
Recently, the Aortic Institute at Yale New Haven Hospital pub-
lished a risk stratification analysis involving their 780-patient co-
hort using regression models. Patients were stratified into 4
categories of yearly risk complications, based on their height-
based aortic height index, which is defined as aortic size/height
ratio. Using code colours and nomograms, the authors illustrated
that a 17-cm-tall man with a 45-mm ascending aorta exhibits a
7% annual risk of aortic dissection, rupture or death. The group
concluded that indexing absolute aortic diameter to
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anthropometric measurements allows for providing individual-
ized risk classification with satisfactory results [17] and that surgi-
cal treatment should be recommended whenever patient-
specific surgical mortality appears to be lower than the estimated
risk of aortic dissection or death.
Other authors have underlined the role of aortic elongation in
TAAD genesis. Unlike the circumferential aorta dilatation, its lon-
gitudinal dilatation, which is also defined as elongation, has been
largely neglected in pathogenic TAAD models. Recently, Kruger
et al. [11] reviewed their experience on 140 patients and pro-
posed the Tübingen Aortic Pathoanatomy (TAIPAN) score to esti-
mate the TAAD risk. They combined the ascending aorta ectasia
and aorta elongation (defined as the central distance between
the sinotubular junction and brachiocephalic trunk) to generate
the following scoring system: ascending aorta diameter <45 mm
= 0, 45–55 mm = 1, >55 mm = 2; ascending aorta length <120
mm = 0, >120 mm = 1. This scoring system was able to identify
23% of pre-TAAD patients and at least twice as many pre-TAAD
patients as the diameter alone. Based on this retrospective mor-
phological analysis, the authors recommended prophylactic
ascending aorta replacement at >_2 points [11]. When applying
the TAIPAN score to our TAAD patient cohort, only 4 (3.4%)
would have been an indication for elective ascending aorta re-
placement (Figure 3). However, our measurements corresponded
to the length of the dissected aorta and not to that of the pre-
dissected aorta, which should be used to calculate the TAIPAN
score. There are no models to quantify the changes in aortic
length due to acute aortic dissection as there are for aortic diam-
eter changes.
As previously mentioned, surgical decision-making requires an
accurate risk/benefit analysis. We must balance the reduced
TAAD incidence, as a result of earlier surgery, against the opera-
tive risk of prophylactic surgery in an asymptomatic patient.
Surgical mortality for elective ascending aorta replacement in
otherwise healthy patients was estimated at 9% in 1997, when
the threshold value of 55 mm was proposed. However, this esti-
mated figure has meanwhile decreased to 1% [11, 18]. The mor-
tality rate for emergency ascending aorta replacement in the
most experienced hands was estimated at 22% in 1997. Notably,
this has not wavered over the last 2 decades, and was 16.9% in
the best series [1, 11, 19]. In our cohort, we observed a 19.6% cu-
mulative mortality rate for 30-day stays. These data should tip
the scales towards earlier surgery because the risk of TAAD has
been proven to be greater than that of elective surgery. The
number needed to treat could be calculated to match historical
data from our experiences. To illustrate, a man with a 45–49-mm
ascending aorta, without any connective-tissue disorders, and a
tricuspid aortic valve exhibits an average annual death risk for
aortic dissection of about 4.7% [20]. The mortality rate for elective
ascending aorta replacement in this otherwise healthy patient is
inferior to 1%. Therefore, preventive surgery reduces the mortal-
ity rate by 3.7%, which translates into an number needed to treat
of 27 (the formal calculation is 100/3.7 = 27). Accordingly, we
should treat 27 patients with 45–49 mm ascending aorta aneur-
ysm to save 1 life.
However, about 7% of entry tears in TAAD are located in the
aortic arch [19], and it is likely that the prophylactic surgical re-
placement of the ascending aorta is not able to prevent the dis-
section of the aortic arch and descending aorta.
We are aware that this study holds several methodological lim-
itations, particularly its retrospective single-centre study design
without any control group, the use of imprecise estimation of
aortic diameter reduction (measurements were performed by a
team of radiologists and surgeons without assessing intra-
observer and interobserver variabilities) and the possibility of
diameter increases due to dissection differing among patients.
Table 1: Gender-, age- and BSA-related ascending aorta diameter upper limits, according to Wolak et al. [10] compared to our cohort
modelled pre-dissection data
Age (years) BSA (m2) Ascending normal (mm)*, n = 2952 Ascending pre-dissection
modelled (mm), n = 102
Diameter difference between
normal and modelled (%)
Female, n = 1147 Male, n = 1805 Female, n = 35 Male, n = 67 Female Male
<45 <1.70 28.4 ± 2.7 28.6 ± 2.2 – – – –
1.70–1.89 30.0 ± 2.2 30.1 ± 3.1 – 34 ± 3.5 – +13.5
1.90–2.09 29.8 ± 2.6 30.9 ± 2.7 38 38.5 ± 2 +29.2 +24.3
>2.1 31.3 32.3 ± 3.0 41 ± 3.5 37 ± 3.5 +31.3 +16.1
45–54 <1.70 29.6 ± 2.8 31.0 ± 3.8 – – – –
1.70–1.89 31.4 ± 2.9 31.7 ± 3.2 42 40 ± 5.5 +34.0 +26.5
1.90–2.09 32.5 ± 3.2 33.1 ± 3.3 – 37 – +12.1
>2.1 34.4 ± 3.1 34.4 ± 3.1 – 42.5 ± 3.5 – +23.2
55–64 <1.70 31.1 ± 2.9 31.5 ± 2.4 39 – +25.8 –
1.70–1.89 31.8 ± 2.6 33.5 ± 3.1 36 ± 2.5 39 ± 3.5 +14.5 +16.5
1.90–2.09 33.0 ± 3.0 34.6 ± 3.3 39 40 +18.2 +15.9
>2.1 35.4 ± 3.3 36.1 ± 3.5 – 39.8 ± 4.5 – +10.5
>65 <1.70 32.5 ± 2.5 33.9 ± 3.3 42.8 ± 3.5 39 +31.1 +15.0
1.70–1.89 33.4 ± 2.9 35.0 ± 3.0 43.5 ± 4.5 39.2 ± 2 +30.0 +12.0
1.90–2.09 34.3 ± 4.2 35.8 ± 3.2 45.1 ± 4 41.5 ± 2.5 +31.3 +15.5
>2.1 32.8 36.8 ± 2.8 – 41.5 ± 4.5 – +13.0
For our data, continuous variables were expressed as mean and standard deviation. An isolated value means that there was only 1 patient. Positive value in the
diameter difference column indicates the diameter increase in the modelled pre-dissected aorta with respect to normal aorta.
*Data from Wolak et al.
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Moreover, we did not take into account TAAD-related morbidity,
such as non-fatal neurological complications and renal function
impairment, both of which affect the quality of life and could po-
tentially be avoided with elective surgery. Although all these limi-
tations could bias the conclusions, in our experience, the current
aortic diameter threshold of 55 mm excludes 99% of TAAD
patients from prophylactic replacement of the ascending aorta.
Therefore, the absolute diameter of 55 mm deserves reappraisal.
We should go beyond the guidelines and move towards a more
personalized therapeutic approach that tailors treatment accord-
ing to a multitude of parameters, in order to provide survival
benefit by replacing the aneurysmal segment of the ascending
aorta before the catastrophic event occurs. An international
taskforce should adapt existing recommendations on surgical
treatment of ascending aortic aneurysm to align with the most
recent scientific evidence, including recommending prophylactic
intervention at smaller aortic sizes in selected patients.
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Epidemiology and clinicopathology of aortic dissection. Chest 2000;117:
1271–8.
[2] Abe T, Yamamoto H, Miyata H, Miyata H, Motomura N, Tokuda Y et al.
Patient trends and outcomes of surgery for type A acute aortic dissection in
Japan: an analysis of more than 10 000 patients from the Japan
Cardiovascular Surgery Database. Eur J CardioThorac Surg 2020;57:660–7.
[3] Howard D, Banerjee A, Fairhead J, Perkins J, Silver LE, Rothwell PM.
Population-based study of incidence and outcome of acute aortic dis-
section and premorbid risk factor control. 10-year results from the
Oxford Vascular Study. Circulation 2013;127:2031–7.
[4] Erbel R, Aboyans V, Boileau C, Bossone E, Di Bartolomeo R, Eggebrecht
H et al. 2014 ESC Guidelines on the diagnosis and treatment of aortic
diseases: document covering acute and chronic aortic diseases of the
thoracic and abdominal aorta of the adult. The Task Force for the
Diagnosis and Treatment of Aortic Diseases of the European Society of
Cardiology (ESC). ESC Committee for Practice Guidelines. Eur Heart J
2014 1;35:2873–926.
[5] Coady MA1, Rizzo JA, Hammond GL, Mandapati D, Darr U, Kopf GS et
al. What is the appropriate size criterion for resection of thoracic aortic
aneurysms? J Thorac Cardiovasc Surg 1997;113:476–91.
[6] Evangelista A, Isselbacher EM, Bossone E, Gleason TG, Eusanio MD,
Sechtem U et al. Insights From the international registry of acute aortic
dissection: a 20-year experience of collaborative clinical research.
Circulation 2018;137:1846–60.
[7] Boening A, Karck M, Conzelmann LO, Easo J, Krüger T, Rylski B et
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